Seven Eight Capital’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,700
Closed -$331K 685
2020
Q2
$331K Buy
+2,700
New +$306K 0.24% 166
2020
Q1
Sell
-22,751
Closed -$2.38M 791
2019
Q4
$2.38M Buy
+22,751
New +$2.55M 0.13% 251
2019
Q1
Sell
-2,124
Closed -$207K 777
2018
Q4
$207K Sell
2,124
-17,500
-89% -$2.3M 0.01% 505
2018
Q3
$3.39M Buy
+19,624
New +$2.83M 0.21% 150
2017
Q3
Sell
-4,424
Closed -$444K 670
2017
Q2
$444K Buy
4,424
+3,300
+294% +$355K 0.06% 322
2017
Q1
$136K Buy
+1,124
New +$138K 0.03% 385
2016
Q4
Sell
-10,300
Closed -$1.37M 667
2016
Q3
$1.37M Buy
+10,300
New +$984K 0.4% 82
2016
Q2
Sell
-1,900
Closed -$137K 713
2016
Q1
$137K Buy
1,900
+1,300
+217% +$71.3K 0.06% 353
2015
Q4
$42K Buy
600
+300
+100% +$24.4K 0.03% 449
2015
Q3
$27K Buy
+300
New +$33.4K 0.02% 393
2014
Q3
Sell
-1,600
Closed -$172K 714
2014
Q2
$172K Buy
+1,600
New +$111K 0.17% 204

Other funds holding GWPH

Seven Eight Capital's GWPH Position: Q3 2020 in Review

Seven Eight Capital sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 2,700 shares — an estimated $331K sold.

Seven Eight Capital first reported a position in GWPH in Q2 2014 and held it in 11 quarters. The position peaked at $3.39M in Q3 2018. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

  • Seven Eight Capital reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
  • Seven Eight Capital sold 2,700 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $331K.
  • Seven Eight Capital first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and held it in 11 quarters.
  • Seven Eight Capital's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3.39M in Q3 2018.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on Seven Eight Capital's 13F filing for Q3 2020, filed 16 Nov 2020.